Skip to main content
Clinical Trials/NCT05639309
NCT05639309
Completed
Not Applicable

Pilot Study to Evaluate the Usefulness of Liver Regional Oxygen Saturation (RSO2) in Preterm Patent Ductus Arteriosus

Seoul St. Mary's Hospital1 site in 1 country40 target enrollmentJanuary 13, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Patent Ductus Arteriosus
Sponsor
Seoul St. Mary's Hospital
Enrollment
40
Locations
1
Primary Endpoint
Day 14 liver regional oxygen saturation
Status
Completed
Last Updated
11 months ago

Overview

Brief Summary

This study evaluates the usefulness of liver perfusion and oxygenation status using regional oxygen saturation (RSO2) values obtained via near-infrared spectroscopy in assessing the hemodynamical significance of patent ductus arteriosus in preterm infants.

Detailed Description

The usefulness of cerebral and renal regional oxygen saturation (RSO2) values for assessing hemodynamically significant patent ductus arteriosus (hsPDA) has been described previously. Meanwhile, autoregulation of the splanchnic organs' perfusion is less developed compared to the cerebral and renal system, which makes the splanchnic bed more prone to perfusion decrease and ischemia in cases of volume depletion or poor circulation. If RSO2 is measure in the liver, the solid organ reflecting the splanchnic bed perfusion status, hsPDA may be more readily identified than when only cerebral and/or renal RSO2 is monitored. This study aims to evaluate the usefulness of liver RSO2 measurement in assessing the hemodynamical significance of patent ductus arteriosus in preterm infants, in comparison to cerebral and renal RSO2.

Registry
clinicaltrials.gov
Start Date
January 13, 2023
End Date
March 31, 2025
Last Updated
11 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sook Kyung Yum

Dr. Sook Kyung Yum

Seoul St. Mary's Hospital

Eligibility Criteria

Inclusion Criteria

  • Gestational age at birth less than 32 weeks
  • Birthweight less than 1,500 grams

Exclusion Criteria

  • Major congenital anomaly
  • chromosomal / genetic anomaly

Outcomes

Primary Outcomes

Day 14 liver regional oxygen saturation

Time Frame: 14 (±3) days after birth

regional oxygen saturation of liver obtained from near-infrared spectroscopy (%)

Day 2 liver regional oxygen saturation

Time Frame: 48 to 72 hours of birth

regional oxygen saturation of liver obtained from near-infrared spectroscopy (%)

Day 7 liver regional oxygen saturation

Time Frame: 7 (±2) days after birth

regional oxygen saturation of liver obtained from near-infrared spectroscopy (%)

Secondary Outcomes

  • PDA liver regional oxygen saturation(When hemodynamically significant patent ductus arteriosus is clinically suspected by the attending physician, up to 28th day of life)

Study Sites (1)

Loading locations...

Similar Trials